ASCO Podcast Coming Soon: Exclusive Interview with FDA Commissioner Scott Gottlieb
Release Date: 01/25/2019
ASCO CEO Meets ASCO CMO: Retiring ASCO Chief Medical Officer Dr. Richard L. Schilsky Gives Far-Reaching Interview on this AiA Podcast
ASCO in Action Podcast
Retiring ASCO Chief Medical Officer Dr. Richard L Schilsky gives a far-reaching interview with ASCO in Action podcast host ASCO CEO Dr. Clifford A. Hudis, who examines Dr. Schilsky’s trailblazing medical career, his leadership in ASCO and indelible mark on its research enterprise, and what he sees for the future of oncology. Dr. Hudis also shares what Dr. Schilsky’s friendship and mentorship has meant to him personally and suggests that he will still be supporting ASCO on critical priorities.
info_outline
Sneak Preview: ASCO to Hold First-ever Virtual Congressional Advocacy Summit and Week of Action in 2020
ASCO in Action Podcast
In the latest ASCO in Action podcast ASCO CEO Dr. Clifford A. Hudis shares a quick preview of what’s to come for the 2020 ASCO Advocacy Summit and Week of Action, which will take place September 14-18.
info_outline
Get to Know Dr. Lori J. Pierce and Her Plans to Improve Equity in Cancer Care During Her ASCO Presidential Year
ASCO in Action Podcast
ASCO President Lori J. Pierce, MD, FASTRO, FASCO, joins ASCO CEO Dr. Clifford A. Hudis in the latest ASCO in Action podcast to discuss how her childhood inspired her to become an oncologist and how the theme of her presidential year, “Equity: Every Patient. Every Day. Everywhere.” is more important than ever as the country responds to a healthcare pandemic that is disproportionately impacting people of color.
info_outline
ASCO Special Report: Resuming Cancer Care Delivery During COVID-19 Pandemic
ASCO in Action Podcast
In the latest ASCO in Action Podcast, American Society of Clinical Oncology (ASCO) CEO Dr. Clifford A. Hudis is joined by Dr. Piyush Srivastava, the past chair of ASCO’s Clinical Practice Committee, to discuss the recently released ASCO Special Report: A Guide to Cancer Care Delivery During the COVID-19 Pandemic, which provides guidance to oncology practices on returning to more routine care, while protecting the health and safety of patients and staff.
info_outline
Listen Now: Ethical Considerations on Allocating Scarce Resources During a Pandemic
ASCO in Action Podcast
In the latest ASCO in Action Podcast, American Society of Clinical Oncology (ASCO) CEO Dr. Clifford A. Hudis is joined by Dr. Jonathan Marron, incoming Chair of ASCO’s Ethics Committee and a lead author of Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic, where they discuss why ASCO developed this guidance, and what patients, families, and the entire medical community need to know about this issue.
info_outline
Drug Repository Programs Address High Costs, Access and Waste Issues for Patients with Cancer
ASCO in Action Podcast
American Society of Clinical Oncology (ASCO) CEO Dr. Clifford A. Hudis is joined by Dr. Ray Page, Past Chair of ASCO’s Clinical Practice Committee, to discuss the important role drug repository programs can play in helping patients afford their treatment and reduce the financial toll on the cancer care delivery system, provided the drugs are maintained within a closed system.
info_outline
Listen Now: New Registry Helps Cancer Community Learn About COVID-19’s Impacts on Cancer Care
ASCO in Action Podcast
In the latest ASCO in Action Podcast, ASCO CEO Dr. Clifford A. Hudis provides an update on a new initiative, the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry), which aims to help the cancer community learn more about the pattern of symptoms and severity of COVID-19 among patients with cancer, as well as how the virus is impacting the delivery of cancer care and patient outcomes.
info_outline
The Science Behind the Science Fiction: CAR T-Cell Therapy
ASCO in Action Podcast
In the latest ASCO in Action Podcast, ASCO CEO Dr. Clifford A. Hudis is joined by Dr. Jason Westin, member of the Government Relations Committee of the Association of Clinical Oncology, to discuss CAR T-cell therapy, a groundbreaking and lifesaving cancer treatment that comes with significant side effects, a jaw-dropping price tag, and limited locations where treatment is currently available.
info_outline
Listen Now: New Podcast Highlights Cancer Advance of the Year
ASCO in Action Podcast
American Society of Clinical Oncology (ASCO) Chief Medical Officer Dr. Richard Schilsky joins Dr. Hudis on the latest ASCO in Action Podcast to discuss the Clinical Cancer Advance of the Year, ASCO’s list of research priorities, and the importance of federal funding in accelerating the pace of progress against cancer.
info_outline
ASCO Patient-Centered Oncology Payment Model: Clearest Way to Move from Fee-for-Service to Value-based Care
ASCO in Action Podcast
ASCO CEO Dr. Clifford A. Hudis is joined by Dr. Jeffrey Ward, a leading contributor to the society’s updated Patient-Centered Oncology Payment (PCOP) model, to discuss how PCOP can improve patient care and lower costs.
info_outlineSubscribe through iTunes and Google Play.
Don’t Miss: Exclusive interview with FDA Commissioner Dr. Scott Gottlieb by ASCO CEO Dr. Clifford A. Hudis on the next ASCO in Action Podcast, coming January 29.
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.
This is Cliff Hudis, CEO of the American Society of Clinical Oncology and host of the ASCO in Action podcast series. For our next podcast I will be speaking with Dr. Scott Gottlieb, Commissioner of the United States Food and Drug Administration. The FDA plays a critical role in delivery of high-quality cancer care by reviewing and approving new cancer treatments. This discussion is sure to be very interesting. It’s going to highlight what the FDA is doing to modernize clinical trials and expedite drug development, and with all of that I urge you to tune in for upcoming information about this special AiA podcast with Dr. Scott Gottlieb.